Jonathan Steinfeld - Concepedia

Author

Jonathan Steinfeld

Research Triangle Park Foundation ORCID

Also Known As

J Steinfeld, J. Steinfeld, JONATHAN STEINFELD, Jonathan Steinfeld, Steinfeld, J

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)National Institutes of Health National Jewish Health National Institute of Allergy and Infectious Diseases

About

Jonathan Steinfeld is an author at Research Triangle Park Foundation specializing in medicine, diagnosis, and asthma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	144
2	Public Health	2	2	49
3	Health Sciences	1	1	22
4	Allergy	1	1	11
5	Allergy Medicine	1	1	11

Jonathan Steinfeld

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis Michael E. Wechsler, Praveen Akuthota, David Jayne, New England Journal of Medicine	2017	995
Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial Florence Roufosse, Jean‐Emmanuel Kahn, Marc E. Rothenberg, Journal of Allergy and Clinical Immunology	2020	176
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis Jonathan Steinfeld, Eric Bradford, Judith C. Brown, Journal of Allergy and Clinical Immunology	2018	145
Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype Atul Gupta, Masanori Ikeda, Bob Geng, Journal of Allergy and Clinical Immunology	2019	99
Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome Fei Kuang, Michael P. Fay, JeanAnne Ware, The Journal of Allergy and Clinical Immunology In Practice ThrombosisAutoimmune DiseaseClinical TherapeuticLong-term Clinical OutcomesHematology	2018	90
Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma Atul Gupta, Isabelle Pouliquen, Daren Austin, Pediatric Pulmonology	2019	86
Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study Gerald J. Gleich, Florence Roufosse, Geoffrey Chupp, The Journal of Allergy and Clinical Immunology In Practice	2021	41
Pharmacogenetic investigation of efficacy response to mepolizumab in eosinophilic granulomatosis with polyangiitis Lynn D. Condreay, Laura R. Parham, Xiaoyan A. Qu, Rheumatology International	2020	28
Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype Benjamin Terrier, David Jayne, Bernhard Hellmich, ACR Open Rheumatology	2023	28
LEAP: A randomized–controlled trial of a lay-educator inpatient asthma education program Jessica L. Rice, Kristen M. Matlack, Marsha D. Simmons, Patient Education and Counseling AsthmaHealth PromotionPatient EducationHealth Profession TrainingPublic Health	2015	27

Page 1